Published in Br Vet J on January 01, 1996
Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg Infect Dis (1998) 5.51
Classification of worldwide bovine tuberculosis risk factors in cattle: a stratified approach. Vet Res (2009) 1.82
Risk Factors for Bovine Tuberculosis (bTB) in Cattle in Ethiopia. PLoS One (2016) 1.38
Cattle owners' awareness of bovine tuberculosis in high and low prevalence settings of the wildlife-livestock interface areas in Zambia. BMC Vet Res (2010) 1.20
Prevalence of bovine tuberculosis in abattoirs of the littoral and Western highland regions of cameroon: a cause for public health concern. Vet Med Int (2010) 0.93
Isolation and characterization of Mycobacterium bovis strains from indigenous Zambian cattle using Spacer oligonucleotide typing technique. BMC Microbiol (2009) 0.90
A review of tuberculosis at the wildlife-livestock-human interface in Zambia. Infect Dis Poverty (2013) 0.84
A review of bovine tuberculosis in the kafue basin ecosystem. Vet Med Int (2011) 0.81
Prevalence of bovine tuberculosis and risk factor assessment in cattle in rural livestock areas of Govuro District in the Southeast of Mozambique. PLoS One (2014) 0.81
Mycobacterium bovis infection at the interface between domestic and wild animals in Zambia. BMC Vet Res (2012) 0.81
Characterization of Mycobacterium bovis from Humans and Cattle in Namwala District, Zambia. Vet Med Int (2014) 0.78
Prevalence and risk factors of bovine tuberculosis in dairy cattle in Eritrea. BMC Vet Res (2016) 0.75
Human and bovine tuberculosis--new threats from an old disease. Br Vet J (1996) 0.75
Failure to detect tuberculosis in Black lechwe antelopes (Kobus leche smithemani) in Zambia. BMC Res Notes (2011) 0.75
Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med (1998) 6.14
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet (2001) 5.01
Impact of HIV on tuberculosis in Zambia: a cross sectional study. BMJ (1990) 3.84
Factors affecting time delay to treatment in a tuberculosis control programme in a sub-Saharan African country: the experience of The Gambia. Int J Tuberc Lung Dis (2001) 3.75
Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination. J Immunol (1999) 2.94
Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis (1999) 2.79
Socio-economic, gender and health services factors affecting diagnostic delay for tuberculosis patients in urban Zambia. Trop Med Int Health (2001) 2.70
Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein. J Exp Med (1976) 2.45
Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc Natl Acad Sci U S A (2000) 2.44
Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia. Tuber Lung Dis (1993) 2.36
Voluntary counseling and HIV testing for pregnant women in the Kassena-Nankana district of northern Ghana: is couple counseling the way forward? AIDS Care (2005) 2.36
Is there an acute-phase response in steady-state sickle cell disease? Lancet (1993) 2.35
Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS (1998) 2.35
Weighing up disability. Lancet (1999) 2.32
Barriers to tuberculosis control in urban Zambia: the economic impact and burden on patients prior to diagnosis. Int J Tuberc Lung Dis (1998) 2.27
Thiacetazone: time to call a halt? Considerations on the use of thiacetazone in African populations with a high prevalence of human immunodeficiency virus infection. Tuber Lung Dis (1996) 2.18
Detection of a mediator derived from endotoxin-stimulated macrohpages that induces the acute phase serum amyloid A response in mice. J Exp Med (1979) 2.03
Monokine-induced synthesis of serum amyloid A protein by hepatocytes. Nature (1980) 1.97
Neonatal bacillus Calmette-Guérin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. Eur J Immunol (2001) 1.96
Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation. J Clin Invest (1978) 1.90
Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun (2001) 1.74
Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial. AIDS (1997) 1.73
A template for improved prevention and control of cardiovascular disease in sub-Saharan Africa. Health Policy Plan (2001) 1.69
Heterogeneity of human serum amyloid A proteins. J Exp Med (1980) 1.68
Nationwide prevalence study of hypertension and related non-communicable diseases in The Gambia. Trop Med Int Health (1997) 1.65
Mycobacterial infections and AIDS. Br Med Bull (1988) 1.59
The impact of HIV on infectiousness of pulmonary tuberculosis: a community study in Zambia. AIDS (1993) 1.58
C57BL/10/CR mice: nonresponders to activation by the lipid a moiety of bacterial lipopolysaccharide. J Immunol (1978) 1.58
In vitro cultivation of Cryptosporidium parvum and screening for anticryptosporidial drugs. Antimicrob Agents Chemother (1990) 1.57
Association of amyloidosis with erythema nodosum leprosum reactions and recurrent neutrophil leucocytosis in leprosy. Lancet (1975) 1.56
An evaluation of low-cost progression markers in HIV-1 seropositive Zambians. HIV Med (2000) 1.51
Atopy, intestinal helminth infection and total serum IgE in rural and urban adult Gambian communities. Clin Exp Allergy (2001) 1.49
Blood pressure patterns and cardiovascular risk factors in rural and urban gambian communities. J Hum Hypertens (2000) 1.46
Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in self collected vaginal swab specimens. Sex Transm Infect (2003) 1.45
Aspects of tuberculosis in Africa. 1. Tuberculosis in Africa in the AIDS era--the role of chemoprophylaxis. Trans R Soc Trop Med Hyg (1993) 1.44
Species of alpha-hemolytic streptococci possessing a C-polysaccharide phosphorylcholine-containing antigen. Infect Immun (1993) 1.42
Mechanism of factor X deficiency in systemic amyloidosis. N Engl J Med (1981) 1.41
Twice-weekly, directly observed treatment for HIV-infected and uninfected tuberculosis patients: cohort study in rural South Africa. AIDS (1999) 1.41
The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis. Tuber Lung Dis (1994) 1.39
T-cell recognition of the 18-kilodalton antigen of Mycobacterium leprae. Infect Immun (1989) 1.39
Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation. Am J Cardiol (1982) 1.34
The biology of SAA: identification of the inducer, in vitro synthesis, and heterogeneity demonstrated with monoclonal antibodies. Ann N Y Acad Sci (1982) 1.29
Control of lipopolysaccharide-high-density lipoprotein interactions by an acute-phase reactant in human serum. Infect Immun (1985) 1.27
Properties of reference Escherichia coli endotoxin and its phthalylated derivative in humans. J Infect Dis (1981) 1.27
Genetic control of endotoxic responses in mice. J Exp Med (1978) 1.24
Induced abortion among women attending antenatal clinics in Yaounde, Cameroon. East Afr Med J (2004) 1.24
A phase I safety and immunogenicity trial with the candidate malaria vaccine RTS,S/SBAS2 in semi-immune adults in The Gambia. Am J Trop Med Hyg (1999) 1.23
Use of prednisolone in the treatment of HIV-positive tuberculosis patients. Q J Med (1993) 1.23
Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tuber Lung Dis (1998) 1.20
Obesity and undernutrition and cardiovascular risk factors in rural and urban Gambian communities. Am J Public Health (2001) 1.20
Preparation for a pneumococcal vaccine trial in The Gambia: individual or community randomisation? Vaccine (1999) 1.18
Asthma, smoking and chronic cough in rural and urban adult communities in The Gambia. Clin Exp Allergy (2001) 1.18
Cellular immune responses of leprosy contacts to fractionated Mycobacterium leprae antigens. Infect Immun (1989) 1.17
Biochemical evidence for the biphasic development of experimental amyloidosis. Lab Invest (1978) 1.17
Interactions of bacterial lipopolysaccharide with acute-phase rabbit serum and isolation of two forms of rabbit serum amyloid A. J Immunol (1982) 1.17
Acute-phase protein response is impaired in severely malnourished children. Clin Sci (Lond) (1993) 1.17
Family history: an opportunity for early interventions and improved control of hypertension, obesity and diabetes. Bull World Health Organ (2001) 1.16
Purified interleukin-1 (IL-1) from human monocytes stimulates acute-phase protein synthesis by rodent hepatocytes in vitro. Immunology (1987) 1.15
Measurement of acute phase proteins for assessing severity of Plasmodium falciparum malaria. J Clin Pathol (1991) 1.14
Do behavioural differences help to explain variations in HIV prevalence in adolescents in sub-Saharan Africa? Trop Med Int Health (2010) 1.14
Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans. QJM (1998) 1.13
The recurrent expression of variable region segments in human IgM anti-DNA autoantibodies. J Immunol (1989) 1.13
Characteristics and specificity of hybridoma antibodies against oocyst antigens of Cryptosporidium parvum from man. Parasite Immunol (1991) 1.13
Polarization of PPD-specific T-cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-alpha or interleukin-12. Am J Respir Cell Mol Biol (2001) 1.12
Immunoglobulin G subclass responses to mycobacterial lipoarabinomannan in HIV-infected and non-infected patients with tuberculosis. Clin Exp Immunol (1993) 1.12
Factors determining the outcome of treatment of adult smear-positive tuberculosis cases in The Gambia. Int J Tuberc Lung Dis (1998) 1.11
Cutaneous reactions to thiacetazone in Zambia--implications for tuberculosis treatment strategies. Trans R Soc Trop Med Hyg (1994) 1.11
Human CD8(+) T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and healthy BCG-vaccinated controls in The Gambia. Infect Immun (2000) 1.09
Comparative study of the antigenic composition of oocyst isolates of Cryptosporidium parvum from different hosts. Parasite Immunol (1992) 1.09
Results of the third immunology of leprosy/immunology of tuberculosis antimycobacterial monoclonal antibody workshop. Infect Immun (1992) 1.09
Recognition of mycobacterial antigens by sera from patients with leprosy. J Clin Microbiol (1988) 1.08
HTLV-1 infection in Papua New Guinea: evidence for serologic false positivity. J Infect Dis (1989) 1.07
Escalating threat from tuberculosis: the third epidemic. Thorax (1995) 1.06
Clinical features and outcome of reversal (type 1) reactions in Hyderabad, India. Int J Lepr Other Mycobact Dis (1993) 1.06
Autopsy findings in HIV-1-infected adults in Kenya. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.06
Analysis of oocyst wall and sporozoite antigens from three Cryptosporidium species. Infect Immun (1992) 1.05
Induction of Th1 cytokine responses by mycobacterial antigens in leprosy. Infect Immun (1996) 1.05
Tuberculin sensitivity and HIV-1 status of patients attending a sexually transmitted diseases clinic in Lusaka, Zambia: a cross-sectional study. Trans R Soc Trop Med Hyg (1995) 1.04
The re-emergence of tuberculosis. Annu Rev Public Health (1994) 1.03
Identifying the determinants of tuberculosis control in resource-poor countries: insights from a qualitative study in The Gambia. Trans R Soc Trop Med Hyg (2004) 1.02
Changing causes of death in the West African town of Banjul, 1942-97. Bull World Health Organ (2001) 1.02
HLA-B*35-restricted CD8 T cell epitopes in the antigen 85 complex of Mycobacterium tuberculosis. J Infect Dis (2001) 1.01
Human monoclonal antibodies to phenolic glycolipid-I derived from patients with leprosy, and production of specific anti-idiotypes. Immunology (1988) 1.01
Clinical and histological discrepancies in diagnosis of ENL reactions classified by assessment of acute phase proteins SAA and CRP. Int J Lepr Other Mycobact Dis (1995) 1.00
Studies of a common idiotype PR4 in autoimmune rheumatic disease. Arthritis Rheum (1988) 1.00
Purification of serum amyloid A and other high density apolipoproteins by hydrophobic interaction chromatography. Anal Biochem (1988) 1.00
Rouleaux-forming serum proteins are involved in the rosetting of Plasmodium falciparum-infected erythrocytes. Exp Parasitol (1999) 1.00
Acute-phase protein synthesis in human hepatoma cells: differential regulation of serum amyloid A (SAA) and haptoglobin by interleukin-1 and interleukin-6. Clin Exp Immunol (1991) 0.99
Conformational flexibility of the serum amyloid precursor SAA. Br J Exp Pathol (1976) 0.97
The influence of placental malaria infection and maternal hypergammaglobulinemia on transplacental transfer of antibodies and IgG subclasses in a rural West African population. J Infect Dis (2001) 0.97
Interaction of the serum amyloid A proteins with phospholipid. J Biol Chem (1983) 0.97
Lipopolysaccharides from Bacteroides fragilis are mitogenic for spleen cells from endotoxin responder and nonresponder mice. Infect Immun (1982) 0.96
Tropical respiratory medicine. 2. Impact of human immunodeficiency virus on tuberculosis in developing countries. Thorax (1994) 0.96
Haemophilus influenzae type b meningitis in The Gambia after introduction of a conjugate vaccine. Lancet (1999) 0.95
HIV-negative infants born to HIV-1 but not HIV-2-positive mothers fail to develop a Bacillus Calmette-Guérin scar. AIDS (1999) 0.95
Polyspecificity of human monoclonal antibodies reactive with Mycobacterium leprae, mitochondria, ssDNA, cytoskeletal proteins, and the acetylcholine receptor. Clin Immunol Immunopathol (1988) 0.95
Design and in vivo evaluation of carvedilol buccal mucoadhesive patches. Pak J Pharm Sci (2008) 0.95